Man Group
CALA

Man Group’s Calithera Biosciences, Inc CALA Stock Holding History

Man Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,106
Closed -$421K – 1979
2020
Q3 		$421K Sell
6,106
-50
-0.8% -$4.36K ﹤0.01% 1579
2020
Q2 		$650K Buy
+6,156
New +$731K ﹤0.01% 1391
2020
Q1 		– Sell
-9,465
Closed -$1.08M – 1977
2019
Q4 		$1.08M Sell
9,465
-245
-3% -$18.4K ﹤0.01% 1484
2019
Q3 		$600K Sell
9,710
-8,671
-47% -$694K ﹤0.01% 1540
2019
Q2 		$1.43M Buy
18,381
+625
+4% +$70.9K 0.01% 1420
2019
Q1 		$2.39M Sell
17,756
-1,555
-8% -$163K 0.01% 1259
2018
Q4 		$1.55M Sell
19,311
-18,133
-48% -$1.79M 0.01% 1305
2018
Q3 		$3.93M Sell
37,444
-4,346
-10% -$414K 0.01% 1121
2018
Q2 		$4.18M Sell
41,790
-4,944
-11% -$560K 0.02% 1036
2018
Q1 		$5.89M Buy
+46,734
New +$7.29M 0.03% 761

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Man Group's CALA Position: Q4 2020 in Review

Man Group sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 6,106 shares — an estimated $421K sold.

Man Group first reported a position in CALA in Q1 2018 and held it in 10 quarters. The position peaked at $5.89M in Q1 2018. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Man Group reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Man Group sold 6,106 Calithera Biosciences, Inc shares in Q4 2020, an estimated $421K.
  • Man Group first reported a position in Calithera Biosciences, Inc in Q1 2018 and held it in 10 quarters.
  • Man Group's Calithera Biosciences, Inc position peaked at $5.89M in Q1 2018.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Man Group's 13F filing for Q4 2020, filed 16 Feb 2021.